Source:http://linkedlifedata.com/resource/pubmed/id/15181372
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-6-7
|
pubmed:abstractText |
Using homozygous human apolipoprotein E2 (apoE2) (2/2)-, apoE3 (3/3)-, or apoE4 (4/4)-knock-in (KI) mice, we aimed to examine whether an apoE isoform-specific exacerbation of delayed infarct expansion occurs after permanent middle cerebral artery occlusion (pMCAO). Compared with 2/2- or 3/3-KI mice, 4/4-KI mice exhibited significantly larger infarct volumes and worse neurologic deficits after pMCAO, with no significant differences between the latter two groups. Infarct volume in 4/4-KI mice was significantly increased from 1 to 5 days after pMCAO, whereas that in 2/2- or 3/3-KI mice was not significantly altered. DNA fragmentation in the peri-infarct area as detected by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphatenick end-labeling was increased to a similar degree in all of the KI mice by 5 days after pMCAO, with no significant differences among the mouse groups. At every time-point examined, human apoE was most markedly expressed in the peri-infarct area, with similar immunoreactivity among the three lines of KI mice. The glial fibrillary acidic protein immunoreactive burden in the peri-infarct area was progressively increased through 7 days in 4/4-KI mice, but not in 2/2- or 3/3-KI mice. Taken together, these data show that the apoE4 isoform acts to aggravate delayed infarct expansion and peri-infarct reactive astrocytosis during the subacute phase of pMCAO in genetically engineered apoE-KI mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E2,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E3,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E4,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0271-678X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
646-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15181372-Animals,
pubmed-meshheading:15181372-Apolipoprotein E2,
pubmed-meshheading:15181372-Apolipoprotein E3,
pubmed-meshheading:15181372-Apolipoprotein E4,
pubmed-meshheading:15181372-Apolipoproteins E,
pubmed-meshheading:15181372-Astrocytes,
pubmed-meshheading:15181372-Brain Ischemia,
pubmed-meshheading:15181372-Cerebral Infarction,
pubmed-meshheading:15181372-Cerebrovascular Circulation,
pubmed-meshheading:15181372-Humans,
pubmed-meshheading:15181372-In Situ Nick-End Labeling,
pubmed-meshheading:15181372-Male,
pubmed-meshheading:15181372-Mice,
pubmed-meshheading:15181372-Mice, Mutant Strains,
pubmed-meshheading:15181372-Neurons,
pubmed-meshheading:15181372-Protein Isoforms,
pubmed-meshheading:15181372-Regional Blood Flow
|
pubmed:year |
2004
|
pubmed:articleTitle |
Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice.
|
pubmed:affiliation |
Institute of Laboratory Animal Science, Saitama Medical Center/School, Kawagoe, Saitama, Japan. t_mori@saitama-med.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|